Labiotech.eu

News and Trends 2 Sep 2015

Arderlyx’s ‘hot potato’: Sanofi changes its mind about €175M pre-clinical research deal

Paris based Sanofi has pulled out of a €176M deal with Californian clinical stage biotech Ardelyx. A licensing deal for a program of pre-clinical candidates treating renal diseases and IBS-C, similar…

September 2, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 2 Sep 2015

Carmat’s Artificial Heart is now inside three patients – how’s it doing?

So preliminary trial results look good - it could be that the next phase will go forward too. The artificial heart of French pioneer Carmat shows several device failures but overcomes…

September 2, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 2 Sep 2015

Novo-expansion! US Based Calibrium and MB2 snapped up by Danish Diabetes Giant

Novo Nordisk has acquired two small Indiana based research Biotechs, Calibrium and MB2, as part of its strategy to establish itself in the US as a major Diabetes research giant.…

September 2, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 1 Sep 2015

Does your business plan need some enhancement? The Science4Life Venture Cup 2016 kicks off today!

The application for Germany's Science4Life Venture Cup 2016 is now open! Join the competition to meet sector-specific experts, benefit from the experiences of former participants and win up to €25k…

September 1, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 1 Sep 2015

Genentech’s Sean Bohen defects to AstraZeneca as CMO

AstraZeneca's Senior management team gets reinforced by Sean Bohen, a top executive from Roche's subsidiary Genentech. Starting in two weeks, he will push late-stage treatments to the market. It's been…

September 1, 2015 - 2 minutesmins - By Philip Hemme

Inside Labiotech 1 Sep 2015

1st day of September, Here Comes Labiotech V3

Hi there, Holidays are over, so let's start September right away in the right dynamic. We worked hard this summer, especially Alexis, our web dev intern, and Nicolas to deliver…

September 1, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 1 Sep 2015

Researcher in Cardiovascular disease? Apply to this new €1,6M Competition for the next treatment

A new research competition is born. The European Society of Cardiology and Boehringer Ingelheim will award €400k to four research projects treating cardiovascular diseases. Big Pharmas like to give a push…

September 1, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 31 Aug 2015

When Tech and Biotech merge, Google and Sanofi partner up to revolutionize Diabetes Management

Taking care of diabetes is still far too complex currently. In future, Sanofi and Google will jointly take care of this problem, hoping to ease the life of millions of…

August 31, 2015 - 2 minutesmins - By Philip Hemme

future biomarkers immuno oncology lymphocytes

News and Trends 31 Aug 2015

Review: The Future of Biomarkers in Immuno-Oncology

Immuno-oncology is a Biotech field that is more than just hype - it could solve one of humanity's biggest health challenges: Cancer. [caption id="attachment_10346" align="alignright" width="272"] Bernhard Sixt, CEO of…

August 31, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 29 Aug 2015

Cambridge’s Algal Innovation Center is soon finished!

The European Energetic Algae project explores the potential of algae as an energy source. Its half a million euros Algal Innovation Center in Cambridge will soon scale up the research. The Energetic…

August 29, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 28 Aug 2015

[Update] Valneva’s duck stem cells attract two new Vaccine-deals

French Valneva continues to sign license agreements for its duck derived stem cell line that produces novel vaccines. Lyon-based Valneva was formed from the 70-year old duck breeder Group Grimaud. It…

August 28, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 28 Aug 2015

FDA shelves UniQure’s Glybera – will the Gene therapy once reach the US market?

The €1.1M drug Glybera was the first gene therapy on the European market. UniQure wants to sell it in the US too, but the FDA makes it much more difficult…

August 28, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 27 Aug 2015

Dutch Immuno-Oncology company raises Massive Series C Financing round

Sofinnova Ventures and Novo A/S step into one of the biggest European series C financing rounds, which is about €72.8 million. The money goes to the Dutch immuno-oncology company Merus…

August 27, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 27 Aug 2015

The 5 things outside Europe you need to know this week (Samsung $1Bn Biotech IPO, Microbiome blindness, Google Biotech)

Hi there! Here are the 5 most important Biotech things that happened outside Europe in the last few days. Enjoy and share! Samsung, Biogen lining up a $1B IPO for…

August 27, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 27 Aug 2015

Dutch Startup receives €2.5M from Europe to Block Cancer’s Spreading

The Eurostars program supports the Dutch start-up Oncodrone with fresh money to bring its metastasis-blocking drug towards clinical trials. Even with a promising technology, it's not easy to succeed in…

August 27, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 26 Aug 2015

It’s proven: The (Almost) Universal Flu Vaccine is Possible!

The foundation stone was laid: A Dutch-American collaboration published in Science the first proof of concept that we could replace the seasonal flu shots with a vaccine that recognizes almost…

August 26, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 26 Aug 2015

Oh dear, Allergan is doing its 4th product recall in 2015 …

Allergan is fighting with manufacturing problems - again! The packaging of some eye treating products were defective and contaminated the eye ointments. Due to safety concerns, these products are recalled…

August 26, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 26 Aug 2015

Ouch! Novo Nordisk fails in Phase III

Novo Nordisk joins UCB and gets knocked down by its drug's final clinical trial. Liraglutide, the already approved adjunct therapy for people with type 2 diabetes won't reach out to…

August 26, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 25 Aug 2015

Leading German Biotechs MorphoSys and Immatics partner to pump up their Immuno-Oncology Therapies

Two German biotechs with highly successful platforms join forces to fight cancer. MorphoSys and Immatics Biotechnologies want to generate novel antibody-based therapeutics against multiple cancer antigens. They are two of…

August 25, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 24 Aug 2015

Monoclonal Antibodies celebrate their 40th birthday, how were they discovered and changed the world?

It's been 40 years now since the first monoclonal antibodies have been manufactured by researchers from UK's Medical Research Council (MRC). Let's go back to the beginning and see how…

August 24, 2015 - 3 minutesmins - By Philip Hemme

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Outsourcing in life science R&D today

Changing the Partner Discovery Game with Connect for Biotech

Looking to expand your network?

Subscribe to our newsletter to get the latest biotech news!